Skip to content
10-K

Annual Report

Spruce Biosciences, Inc. SPRB

0001193125-26-097558

← back to feed
Filed
Mar 9, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 3, 2026 1.37M sh
Shares Diluted FY 2025 · Dec 31, 2025 766.6K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 550.15K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$33.33M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$55.96M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $124K
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $1.62M
Cash And Equivalents FY 2025 · Dec 31, 2025 $48.91M
Cash And Equivalents FY 2025 · Dec 31, 2024 $38.75M
Stockholders Equity FY 2025 · Dec 31, 2025 $42.52M
Stockholders Equity FY 2025 · Dec 31, 2024 $28.82M
Stockholders Equity FY 2025 · Dec 31, 2023 $76.51M
Current Liabilities FY 2025 · Dec 31, 2025 $10.09M
Current Liabilities FY 2025 · Dec 31, 2024 $15.25M
Total Liabilities FY 2025 · Dec 31, 2025 $10.51M
Total Liabilities FY 2025 · Dec 31, 2024 $16.39M
Current Assets FY 2025 · Dec 31, 2025 $52.11M
Current Assets FY 2025 · Dec 31, 2024 $44.21M
Total Assets FY 2025 · Dec 31, 2025 $53.02M
Total Assets FY 2025 · Dec 31, 2024 $45.21M
Eps Diluted FY 2025 · Dec 31, 2025 −$50.83
Eps Diluted restated FY 2025 · Dec 31, 2024 −$96.40
Eps Basic FY 2025 · Dec 31, 2025 −$50.83
Eps Basic restated FY 2025 · Dec 31, 2024 −$96.40
Sga Expense FY 2025 · Dec 31, 2025 $16.99M
Sga Expense FY 2025 · Dec 31, 2024 $14.64M
Rd Expense FY 2025 · Dec 31, 2025 $19.52M
Rd Expense FY 2025 · Dec 31, 2024 $46.42M
Net Income FY 2025 · Dec 31, 2025 −$38.97M
Net Income FY 2025 · Dec 31, 2024 −$53.04M
Operating Income FY 2025 · Dec 31, 2025 −$36.51M
Operating Income FY 2025 · Dec 31, 2024 −$56.15M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $4.91M